Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P349
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baird, Jason
Friedman, David
Cottam, Benjamin
Crittenden, Marka
Gough, Michael
Article History
First Online: 4 November 2015